• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房纤维化作为心房颤动发展的主要因素:事实和差距。

Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps.

机构信息

Cardiology Department, Mitera General Hospital, Hygeia Group, Athens, Greece.

Center of Basic Research, Biomedical Research Foundation Academy of Athens, Greece.

出版信息

Europace. 2020 Mar 1;22(3):342-351. doi: 10.1093/europace/euaa009.

DOI:10.1093/europace/euaa009
PMID:31998939
Abstract

Atrial fibrillation (AF), the most commonly diagnosed arrhythmia, affects a notable percentage of the population and constitutes a major risk factor for thromboembolic events and other heart-related conditions. Fibrosis plays an important role in the onset and perpetuation of AF through structural and electrical remodelling processes. Multiple molecular pathways are involved in atrial substrate modification and the subsequent maintenance of AF. In this review, we aim to recapitulate underlying molecular pathways leading to atrial fibrosis and to indicate existing gaps in the complex interplay of atrial fibrosis and AF.

摘要

心房颤动(AF)是最常见的心律失常,影响着相当大比例的人群,是血栓栓塞事件和其他与心脏相关疾病的主要危险因素。纤维化通过结构和电重构过程在 AF 的发生和持续中起着重要作用。多种分子途径参与了心房基质的修饰和随后的 AF 的维持。在这篇综述中,我们旨在概述导致心房纤维化的潜在分子途径,并指出心房纤维化和 AF 复杂相互作用中存在的差距。

相似文献

1
Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps.心房纤维化作为心房颤动发展的主要因素:事实和差距。
Europace. 2020 Mar 1;22(3):342-351. doi: 10.1093/europace/euaa009.
2
Atrial fibrosis underlying atrial fibrillation (Review).心房纤维化在心房颤动中的作用(综述)。
Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2020.4842. Epub 2021 Jan 15.
3
Atrial structure and function and its implications for current and emerging treatments for atrial fibrillation.心房结构与功能及其对当前和新兴房颤治疗方法的影响。
Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):152-67. doi: 10.1016/j.pcad.2015.08.004. Epub 2015 Aug 4.
4
Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards.心房纤维化和房颤的基质特征:向前迈进的时候到了。
J Cardiovasc Electrophysiol. 2021 Apr;32(4):1147-1160. doi: 10.1111/jce.14987. Epub 2021 Mar 17.
5
Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis.阵发性和持续性心房颤动的病理生理学:转子、病灶与纤维化
Heart Lung Circ. 2017 Sep;26(9):887-893. doi: 10.1016/j.hlc.2017.05.119. Epub 2017 May 24.
6
Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review.影像学在心房颤动患者心房纤维化评估中的作用:最新综述。
Eur Heart J Cardiovasc Imaging. 2014 Jan;15(1):1-5. doi: 10.1093/ehjci/jet116. Epub 2013 Jun 24.
7
Atrial fibrosis: a risk stratifier for atrial fibrillation.心房纤维化:心房颤动的风险分层指标
Expert Rev Cardiovasc Ther. 2013 Feb;11(2):155-60. doi: 10.1586/erc.12.174.
8
Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation.预防心房颤动持续存在的新型上游方法。
Heart Fail Clin. 2016 Apr;12(2):309-22. doi: 10.1016/j.hfc.2015.08.024.
9
Novel upstream approaches to prevent atrial fibrillation perpetuation.预防心房颤动持续存在的新型上游方法。
Cardiol Clin. 2014 Nov;32(4):637-50. doi: 10.1016/j.ccl.2014.07.004. Epub 2014 Aug 22.
10
Three-dimensional Integrated Functional, Structural, and Computational Mapping to Define the Structural "Fingerprints" of Heart-Specific Atrial Fibrillation Drivers in Human Heart Ex Vivo.三维综合功能、结构和计算图谱,以确定人心外植体中心脏特异性心房颤动驱动因素的结构“指纹”。
J Am Heart Assoc. 2017 Aug 22;6(8):e005922. doi: 10.1161/JAHA.117.005922.

引用本文的文献

1
The senescence-inducing factor IGFBP7 and risk of atrial fibrillation: findings from the PREVEND study.衰老诱导因子IGFBP7与心房颤动风险:PREVEND研究的结果
NPJ Cardiovasc Health. 2025;2(1):42. doi: 10.1038/s44325-025-00079-1. Epub 2025 Aug 12.
2
The impact of left atrial voltage abnormality on ablation outcomes in paroxysmal atrial fibrillation and its pre-procedural predictors: an observational retrospective study.左心房电压异常对阵发性心房颤动消融结果的影响及其术前预测因素:一项观察性回顾性研究。
Egypt Heart J. 2025 Jul 31;77(1):77. doi: 10.1186/s43044-025-00664-w.
3
Interactions between atrial fibrosis and inflammation in atrial fibrillation.
心房颤动中心房纤维化与炎症之间的相互作用。
Front Cardiovasc Med. 2025 Jul 10;12:1578148. doi: 10.3389/fcvm.2025.1578148. eCollection 2025.
4
Atrial Cardiomyopathy in Atrial Fibrillation: A Multimodal Diagnostic Framework.心房颤动中的心房心肌病:多模态诊断框架
Diagnostics (Basel). 2025 May 10;15(10):1207. doi: 10.3390/diagnostics15101207.
5
Blood urea nitrogen to serum albumin ratio as a prognostic marker for 28-day mortality in atrial fibrillation: a retrospective cohort study.血尿素氮与血清白蛋白比值作为心房颤动患者28天死亡率的预后标志物:一项回顾性队列研究。
Front Cardiovasc Med. 2025 May 9;12:1533575. doi: 10.3389/fcvm.2025.1533575. eCollection 2025.
6
Chronic obstructive pulmonary disease is associated with higher recurrence rates of atrial fibrillation following catheter ablation.慢性阻塞性肺疾病与导管消融术后心房颤动的较高复发率相关。
Indian Pacing Electrophysiol J. 2025 May-Jun;25(3):148-156. doi: 10.1016/j.ipej.2025.05.004. Epub 2025 May 22.
7
Gut microbiota and atrial cardiomyopathy.肠道微生物群与心房心肌病
Front Cardiovasc Med. 2025 Feb 4;12:1541278. doi: 10.3389/fcvm.2025.1541278. eCollection 2025.
8
The role of long non-coding RNAs in cardiovascular diseases: A comprehensive review.长链非编码RNA在心血管疾病中的作用:综述
Noncoding RNA Res. 2024 Dec 28;11:158-187. doi: 10.1016/j.ncrna.2024.12.009. eCollection 2025 Apr.
9
Genetic and Molecular Underpinnings of Atrial Fibrillation.心房颤动的遗传和分子基础
NPJ Cardiovasc Health. 2024;1. doi: 10.1038/s44325-024-00035-5. Epub 2024 Dec 4.
10
Freeze the clock: earlier catheter ablation for atrial fibrillation delivers better outcomes.冻结时钟:早期进行心房颤动导管消融可带来更好的治疗效果。
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf010.